66 related articles for article (PubMed ID: 7872065)
21. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
22. In vitro binding of vitamin D receptor occupied by 24R,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene.
Uchida M; Ozonco K; Pike JW
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):181-7. PubMed ID: 9191975
[TBL] [Abstract][Full Text] [Related]
23. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
[TBL] [Abstract][Full Text] [Related]
24. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
25. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
Uchida M; Ozono K; Pike JW
J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
[TBL] [Abstract][Full Text] [Related]
26. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
27. [Vitamin D].
Miyaura C; Suda T
Nihon Rinsho; 1993 Apr; 51(4):893-900. PubMed ID: 8483269
[TBL] [Abstract][Full Text] [Related]
28. The genomic mechanism of action of 1,25-dihydroxyvitamin D3.
Ozono K; Sone T; Pike JW
J Bone Miner Res; 1991 Oct; 6(10):1021-7. PubMed ID: 1665675
[TBL] [Abstract][Full Text] [Related]
29. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
30. Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.
Norman AW; Okamura WH; Bishop JE; Henry HL
Mol Cell Endocrinol; 2002 Nov; 197(1-2):1-13. PubMed ID: 12431790
[TBL] [Abstract][Full Text] [Related]
31. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways.
Farach-Carson MC; Ridall AL
Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195
[TBL] [Abstract][Full Text] [Related]
32. What do we learn from the genome-wide perspective on vitamin D3?
Carlberg C
Anticancer Res; 2015 Feb; 35(2):1143-51. PubMed ID: 25667505
[TBL] [Abstract][Full Text] [Related]
33. The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells.
Paredes R; Arriagada G; Cruzat F; Olate J; Van Wijnen A; Lian J; Stein G; Stein J; Montecino M
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):269-71. PubMed ID: 15225783
[TBL] [Abstract][Full Text] [Related]
34. Developmental changes in responsiveness to vitamin D metabolites.
Sömjen D; Earón Y; Harell S; Shimshoni Z; Weisman Y; Harell A; Kaye AM; Binderman I
J Steroid Biochem; 1987; 27(4-6):807-13. PubMed ID: 3320560
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms regulating differential activation of membrane-mediated signaling by 1alpha,25(OH)2D3 and 24R,25(OH)2D3.
Boyan BD; Jennings EG; Wang L; Schwartz Z
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):309-15. PubMed ID: 15225791
[TBL] [Abstract][Full Text] [Related]
36. The role of vitamin D in breast cancer risk and progression.
Vanhevel J; Verlinden L; Doms S; Wildiers H; Verstuyf A
Endocr Relat Cancer; 2022 Jan; 29(2):R33-R55. PubMed ID: 34935629
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
